Associated Papers
High throughput profiling of undifferentiated pleomorphic sarcomas identifies two main subgroups with distinct immune profile, clinical outcome and sensitivity to targeted therapies.
Toulmonde M et al.
Ebiomedicine, 2020
33254023 (PubMed )
Supplement: mmc5.xlsx › UPS_somatic_mutations_filtered
Apoptosis gene polymorphisms and risk of prostate cancer: a hospital-based study of German patients treated with brachytherapy.
Meyer A et al.
Urologic Oncology, 2013
Prostate cancer risk is not altered by TP53AIP1 germline mutations in a German case-control series.
Luedeke M et al.
Plos One, 2012
Truncating variants in p53AIP1 disrupting DNA damage-induced apoptosis are associated with prostate cancer risk.
Wang X et al.
Cancer Research, 2006
Select a paper to view details